Display Settings:

Format

Send to:

Choose Destination
    Mol Cell Biol. 1998 Feb;18(2):753-61.

    Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

    Source

    The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA. Lundberg@wi.mit.edu

    Abstract

    The retinoblastoma protein (pRb) acts to constrain the G1-S transition in mammalian cells. Phosphorylation of pRb in G1 inactivates its growth-inhibitory function, allowing for cell cycle progression. Although several cyclins and associated cyclin-dependent kinases (cdks) have been implicated in pRb phosphorylation, the precise mechanism by which pRb is phosphorylated in vivo remains unclear. By inhibiting selectively either cdk4/6 or cdk2, we show that endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb only partially, a process that is likely to be completed by cyclin E-cdk2 complexes. Furthermore, cyclin E-cdk2 is unable to phosphorylate pRb in the absence of prior phosphorylation by cyclin D-cdk4/6 complexes. Complete phosphorylation of pRb, inactivation of E2F binding, and activation of E2F transcription occur only after sequential action of at least two distinct G1 cyclin kinase complexes.

    PMID:
    9447971
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC108786
    Free PMC Article

    Images from this publication.See all images (6) Free text

    FIG. 1
    FIG. 3
    FIG. 5
    FIG. 2
    FIG. 4
    FIG. 6

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk